
Anisa Mohanty
Professional Bio
Anisa Mohanty advises life sciences companies on regulatory, compliance, enforcement, policy, and legislative matters arising under the Federal Food, Drug, and Cosmetic Act (FDCA). She counsels pharmaceutical, medical device, and consumer product companies on premarket pathways, advertising and promotion, and current Good Manufacturing Practice (cGMP) and Quality System requirements. Read Anisa Mohanty's full bio.
FDA 2019 Year in Review
Health & Life Sciences News ·
Is Your Software a Medical Device? FDA Issues Six Digital Health Guidance Documents
Of Digital Interest ·
Reviewing Key Principles from FDA’s Artificial Intelligence White Paper
Of Digital Interest ·
FDA’s Breakthrough Device Program: Opportunities and Challenges for Device Developers
Of Digital Interest ·